Scott M. Wasserman insider trades

Open-market stock purchases and sales by Scott M. Wasserman, Chief Medical Officer at Kailera Therapeutics, Inc, from SEC Form 4 filings since Apr 16, 2026.

Recent trades

DateStockTradeValue
Apr 16, 2026KLRA Kailera Therapeutics, IncBought (not open market)—

Companies traded

  • KLRA Kailera Therapeutics, Inc: other filings, last Apr 16, 2026

Get free alerts when Scott M. Wasserman files a new trade →